DK0531119T3 - N,N,N-trisubstituerede 5-bis-aminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA: cholesterol-acyltransferase - Google Patents

N,N,N-trisubstituerede 5-bis-aminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA: cholesterol-acyltransferase

Info

Publication number
DK0531119T3
DK0531119T3 DK92307981.8T DK92307981T DK0531119T3 DK 0531119 T3 DK0531119 T3 DK 0531119T3 DK 92307981 T DK92307981 T DK 92307981T DK 0531119 T3 DK0531119 T3 DK 0531119T3
Authority
DK
Denmark
Prior art keywords
inhibitors
aminomethylene
acyltransferase
trisubstituted
coa
Prior art date
Application number
DK92307981.8T
Other languages
Danish (da)
English (en)
Inventor
William Floyd Fobare
Donald Peter Strike
Patrick Michael Andrae
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/755,918 external-priority patent/US5136039A/en
Priority claimed from US07/847,127 external-priority patent/US5177219A/en
Priority claimed from US07/879,494 external-priority patent/US5164505A/en
Priority claimed from US07/914,886 external-priority patent/US5187284A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0531119T3 publication Critical patent/DK0531119T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK92307981.8T 1991-09-06 1992-09-03 N,N,N-trisubstituerede 5-bis-aminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA: cholesterol-acyltransferase DK0531119T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/755,918 US5136039A (en) 1991-09-06 1991-09-06 N,N',N'-trisubstituted-5-bis-aminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA:cholesterol-acyl transferase
US07/847,127 US5177219A (en) 1992-03-06 1992-03-06 N-phenyl-N'-thienylmethyl-bis-diamino-5-methylene-1,3-dioxane-4,6-dione compounds
US07/879,494 US5164505A (en) 1992-05-07 1992-05-07 N-phenyl-N'-alkyl-N'-pyridylmethyl-bis-diamino-5-methylene-1,3-dioxane-4,6-diones
US07/914,886 US5187284A (en) 1992-07-22 1992-07-22 N-phenyl-N'-benzothienylmethyl-bis-diamino-5-methylene-1,3-dioxane-4,6-dione derivatives

Publications (1)

Publication Number Publication Date
DK0531119T3 true DK0531119T3 (da) 1995-11-27

Family

ID=27505672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92307981.8T DK0531119T3 (da) 1991-09-06 1992-09-03 N,N,N-trisubstituerede 5-bis-aminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA: cholesterol-acyltransferase

Country Status (12)

Country Link
EP (1) EP0531119B1 (ko)
JP (1) JPH05194502A (ko)
KR (1) KR930006000A (ko)
AT (1) ATE128978T1 (ko)
AU (1) AU652852B2 (ko)
DE (1) DE69205383T2 (ko)
DK (1) DK0531119T3 (ko)
ES (1) ES2077985T3 (ko)
GR (1) GR3018392T3 (ko)
HU (1) HUT65376A (ko)
MX (1) MX9204939A (ko)
NZ (1) NZ244210A (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24576B1 (es) 2016-05-04 2022-02-04 Centro De Investig Y Desarrollo De Medicamentos Cidem Compuesto fenólico y combinación del mismo con una benzodiazepina fusionada a 1,4-dihidropiridina para el tratamiento de afecciones del sistema nervioso central y vascular

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0678298B2 (ja) * 1988-03-30 1994-10-05 ワーナー‐ランバート・コンパニー Ｎ‐〔〔（２，６‐ジ置換）フエニル〕‐ｎ′‐アリールアルキル〕尿素
US5179216A (en) * 1990-08-16 1993-01-12 American Home Products Corporation N,n', n'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-coa:cholesterol-acyl transferase

Also Published As

Publication number Publication date
AU2212692A (en) 1993-03-11
EP0531119B1 (en) 1995-10-11
HUT65376A (en) 1994-05-02
NZ244210A (en) 1994-08-26
MX9204939A (es) 1993-03-01
ES2077985T3 (es) 1995-12-01
KR930006000A (ko) 1993-04-20
GR3018392T3 (en) 1996-03-31
AU652852B2 (en) 1994-09-08
DE69205383T2 (de) 1996-03-21
JPH05194502A (ja) 1993-08-03
EP0531119A1 (en) 1993-03-10
ATE128978T1 (de) 1995-10-15
DE69205383D1 (de) 1995-11-16
HU9202849D0 (en) 1992-11-30

Similar Documents

Publication Publication Date Title
FI931707A0 (fi) 1,2,4-oxadiazolyl-fenoxialkylisoxazoler och deras anvaendning som virusmotarbetande aemnen
CO4950553A1 (es) Compuestos de 7-tetrahidroisoquinolinas y procedimiento para su preparacion
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
IE861633L (en) Carboxamide indole derivatives
DK0531119T3 (da) N,N,N-trisubstituerede 5-bis-aminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA: cholesterol-acyltransferase
NO961404L (no) 4-indolylpiperazinyl-derivater
CA2101952A1 (en) Sulfonylurea derivatives, their preparation and their use
RU93058270A (ru) Производные сульфонилмочевины, способ их получения и их применение
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DK0471493T3 (da) N,N,N-Trisubstituerede-5-bisaminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA:cholesterol-acyltransferase
NO870251D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
ES8406432A1 (es) Un procedimiento para preparar esteres del acido fenoxifenoxipropionico.
TW325460B (en) Imidic acid derivatives
MX9605679A (es) 3-fenilpirazoles sustituidos.